Correlation Between Forte Biosciences and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Forte Biosciences and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Mineralys Therapeutics,.
Diversification Opportunities for Forte Biosciences and Mineralys Therapeutics,
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Forte and Mineralys is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Forte Biosciences and Mineralys Therapeutics,
Given the investment horizon of 90 days Forte Biosciences is expected to generate 5.21 times more return on investment than Mineralys Therapeutics,. However, Forte Biosciences is 5.21 times more volatile than Mineralys Therapeutics, Common. It trades about 0.27 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.09 per unit of risk. If you would invest 483.00 in Forte Biosciences on August 24, 2024 and sell it today you would earn a total of 1,069 from holding Forte Biosciences or generate 221.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Forte Biosciences vs. Mineralys Therapeutics, Common
Performance |
Timeline |
Forte Biosciences |
Mineralys Therapeutics, |
Forte Biosciences and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Forte Biosciences and Mineralys Therapeutics,
The main advantage of trading using opposite Forte Biosciences and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.Forte Biosciences vs. Lyra Therapeutics | Forte Biosciences vs. Hookipa Pharma | Forte Biosciences vs. Cingulate Warrants | Forte Biosciences vs. SAB Biotherapeutics |
Mineralys Therapeutics, vs. Integrated Drilling Equipment | Mineralys Therapeutics, vs. Xponential Fitness | Mineralys Therapeutics, vs. Lipocine | Mineralys Therapeutics, vs. Delek Drilling |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |